Literature DB >> 22767983

A new strategy for endoscopic staging of laryngeal carcinoma: multistep endoscopy.

E Crosetti1, F Pilolli, G Succo.   

Abstract

At present, it is difficult to identify a gold standard for endoscopic staging of laryngeal cancer, especially considering the large number of endoscopic instruments available. We have coined the term multistep endoscopy to describe a method for staging laryngeal precancerous and neoplastic lesions that sequentially uses several endoscopic tools including high definition white light endoscopy (HDTV), stroboscopy and autofluorescence endoscopy. During the period from November 2007 to November 2009, 140 patients with a suspect laryngeal lesion underwent multistep endoscopy at the Department of Otorhinolaryngology at Martini Hospital in Turin. All patients were subjected to a series of endoscopic examinations in indirect laryngoscopy (white light endoscopy coupled to a HDTV camera, laryngostroboscopy, indirect autofluorescence) followed by white light endoscopy coupled to a HDTV camera and autofluorescence in direct microlaryngoscopy. The aim of the present prospective study was to evaluate the utility of multistep endoscopy in the diagnostic work-up of laryngeal lesions. Multistep endoscopy showed a higher sensitivity and "biological" predictive value in early cancer and precancerous lesions of the larynx (sensitivity, 97.9%; specificity, 90.5%) compared to individual endoscopic tools. It allows for better therapeutic planning of superficial lesions and more accurate orientation when performing mapping biopsies on diffuse lesions. In our opinion, more widespread use of indirect autofluorescence endoscopy during follow-up may be warranted to search for synchronous/metachronous second tumours of the upper aerodigestive tract.

Entities:  

Keywords:  Laryngeal cancer staging; Laryngeal endoscopy; Multistep endoscopy

Mesh:

Year:  2012        PMID: 22767983      PMCID: PMC3385054     

Source DB:  PubMed          Journal:  Acta Otorhinolaryngol Ital        ISSN: 0392-100X            Impact factor:   2.124


  11 in total

1.  Laryngoscopic detection of pharyngeal carcinoma in situ with narrowband imaging.

Authors:  Akihito Watanabe; Hitoshi Tsujie; Masanobu Taniguchi; Masao Hosokawa; Masahiro Fujita; Shigeyuki Sasaki
Journal:  Laryngoscope       Date:  2006-04       Impact factor: 3.325

2.  Narrow band imaging and high definition television in the assessment of laryngeal cancer: a prospective study on 279 patients.

Authors:  Cesare Piazza; Daniela Cocco; Luigi De Benedetto; Francesca Del Bon; Piero Nicolai; Giorgio Peretti
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-10-14       Impact factor: 2.503

3.  Significance of autofluorescence for the optical demarcation of field cancerisation in the upper aerodigestive tract.

Authors:  A Fryen; H Glanz; W Lohmann; T Dreyer; R M Bohle
Journal:  Acta Otolaryngol       Date:  1997-03       Impact factor: 1.494

Review 4.  Fluorescence detection of bladder cancer: a review.

Authors:  Marie-Ange D'Hallewin; Lina Bezdetnaya; François Guillemin
Journal:  Eur Urol       Date:  2002-11       Impact factor: 20.096

Review 5.  Narrow-band imaging: a new tool for evaluation of head and neck squamous cell carcinomas. Review of the literature.

Authors:  C Piazza; O Dessouky; G Peretti; D Cocco; L De Benedetto; P Nicolai
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-04       Impact factor: 2.124

6.  Efficacy of autofluoroscence videoendoscopy in the diagnosis of laryngeal lesions.

Authors:  R Saetti; F Derosas; M Silvestrini; S Narne
Journal:  Acta Otorhinolaryngol Ital       Date:  2007-08       Impact factor: 2.124

7.  Autofluorescence endoscopy in the diagnosis of early laryngeal cancer and its precursor lesions.

Authors:  Karin Malzahn; Thomas Dreyer; Hiltrud Glanz; Christoph Arens
Journal:  Laryngoscope       Date:  2002-03       Impact factor: 3.325

8.  Indirect autofluorescence laryngoscopy in the diagnosis of laryngeal cancer and its precursor lesions.

Authors:  C Arens; T Dreyer; H Glanz; K Malzahn
Journal:  Eur Arch Otorhinolaryngol       Date:  2003-07-17       Impact factor: 2.503

9.  Squamous cell carcinoma in situ at oropharyngeal and hypopharyngeal mucosal sites.

Authors:  Manabu Muto; Mari Nakane; Chikatoshi Katada; Yasushi Sano; Atsushi Ohtsu; Hiroyasu Esumi; Satoshi Ebihara; Shigeaki Yoshida
Journal:  Cancer       Date:  2004-09-15       Impact factor: 6.860

10.  Performance differences in laparoscopic surgical skills between true high-definition and three-chip CCD video systems.

Authors:  M Hagiike; E H Phillips; G Berci
Journal:  Surg Endosc       Date:  2007-08-15       Impact factor: 3.453

View more
  4 in total

1.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

2.  Proposal of a form for the collection of videolaryngostroboscopy basic findings.

Authors:  Andrea Ricci-Maccarini; Giuseppe Bergamini; Rolando Fustos
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-05-22       Impact factor: 2.503

3.  Modular approach in OPHL: are there preoperative predictors?

Authors:  Andy Bertolin; Marco Lionello; Marco Ghizzo; Emanuela Barbero; Erika Crosetti; Giuseppe Rizzotto; Giovanni Succo
Journal:  Acta Otorhinolaryngol Ital       Date:  2020-10       Impact factor: 2.124

4.  Direct autofluorescence during CO2 laser surgery of the larynx: can it really help the surgeon?

Authors:  G Succo; P Garofalo; M Fantini; V Monticone; G C Abbona; E Crosetti
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-06       Impact factor: 2.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.